Anti-inflammatory Therapeutics Market 2027 By Drug Type, Indication, Distribution Channel and Geography | The Insight Partners

Anti-inflammatory Therapeutics Market to 2027 - Global Analysis and Forecasts By Drug Type (Non-steroidal Anti-inflammatory Drugs, Anti-inflammatory Biologics, Corticosteroids); Indication (Multiple Sclerosis, Inflammatory Bowel Disease, Respiratory Diseases, Asthma); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Distribution) and Geography

Report Code: TIPRE00007248 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Anti-inflammatory therapeutics are drugs or molecules that are used to reduce inflammation and swellings caused due to drug reaction, injuries or others. These molecules are made up of analgesics that helps in pain and inflammation reduction. In the market there are various market players that are offering anti-inflammatory drugs. These are distributed by various means such as drug stores, online distribution and others.

MARKET DYNAMICS

The anti-inflammatory therapeutics market is forecasted to grow due to the key factors such as rising chronic diseases, rising number of wounds and injuries, rising generic pharmaceutical markets and others. The market is likely to have several growth opportunities due to the expansion of various companies through local distribution and rising approvals for the generic pharmaceutical products.

MARKET SCOPE

The "Global Anti-inflammatory Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Anti-inflammatory therapeutics market with detailed market segmentation by drug type, indication, distribution channel and geography. The global anti-inflammatory therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading anti-inflammatory therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global anti-inflammatory therapeutics market is segmented on the basis of drug type, indication and distribution channel. On the basis of the drug type the market is classified as non-steroidal anti-inflammatory drugs, anti-inflammatory biologics, and corticosteroids. Based on the indication the market is segmented as multiple sclerosis, inflammatory bowel disease, respiratory diseases, and asthma. On the basis of distribution channel the market is divided into retail pharmacies, hospital pharmacies, and online distribution.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global anti-inflammatory therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-inflammatory therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting anti-inflammatory therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anti-inflammatory therapeutics market in these regions.

MARKET PLAYERS


The reports cover key developments in the anti-inflammatory therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Anti-inflammatory therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for Anti-inflammatory therapeutics market in the global market. Below mentioned is the list of few companies engaged in the anti-inflammatory therapeutics market.

The report also includes the profiles of key anti-inflammatory therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  •  AbbVie Inc.
  •  Pfizer Inc.
  •  GlaxoSmithKline plc
  •  Merck and Co., Inc.
  •  Novartis AG
  •  F. Hoffmann-La Roche AG
  •  Eli Lily and Company
  •  AstraZeneca PLC.
  •  Amgen Inc.
  •  Johnson and Johnson Services Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti-Inflammatory Therapeutics Market - By Drug Type
1.3.2 Anti-Inflammatory Therapeutics Market - By Indication
1.3.3 Anti-Inflammatory Therapeutics Market - By Distribution Channel
1.3.4 Anti-Inflammatory Therapeutics Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANTI-INFLAMMATORY THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANTI-INFLAMMATORY THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ANTI-INFLAMMATORY THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI-INFLAMMATORY THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. ANTI-INFLAMMATORY THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ANTI-INFLAMMATORY THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
7.3.1. Overview
7.3.2. Non-steroidal Anti-inflammatory Drugs Market Forecast and Analysis
7.4. ANTI-INFLAMMATORY BIOLOGICS
7.4.1. Overview
7.4.2. Anti-inflammatory Biologics Market Forecast and Analysis
7.5. CORTICOSTEROIDS
7.5.1. Overview
7.5.2. Corticosteroids Market Forecast and Analysis
8. ANTI-INFLAMMATORY THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. MULTIPLE SCLEROSIS
8.3.1. Overview
8.3.2. Multiple Sclerosis Market Forecast and Analysis
8.4. INFLAMMATORY BOWEL DISEASE
8.4.1. Overview
8.4.2. Inflammatory Bowel Disease Market Forecast and Analysis
8.4.3. Crohn's Disease Market
8.4.3.1. Overview
8.4.3.2. Crohn's Disease Market Forecast and Analysis
8.4.4. Ulcerative Colitis Market
8.4.4.1. Overview
8.4.4.2. Ulcerative Colitis Market Forecast and Analysis
8.5. RESPIRATORY DISEASES
8.5.1. Overview
8.5.2. Respiratory Diseases Market Forecast and Analysis
8.5.3. Chronic Obstructive Pulmonary Disease Market
8.5.3.1. Overview
8.5.3.2. Chronic Obstructive Pulmonary Disease Market Forecast and Analysis
8.6. ASTHMA
8.6.1. Overview
8.6.2. Asthma Market Forecast and Analysis
9. ANTI-INFLAMMATORY THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Retail Pharmacies Market Forecast and Analysis
9.4. HOSPITAL PHARMACIES
9.4.1. Overview
9.4.2. Hospital Pharmacies Market Forecast and Analysis
9.5. ONLINE DISTRIBUTION
9.5.1. Overview
9.5.2. Online Distribution Market Forecast and Analysis
10. ANTI-INFLAMMATORY THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Anti-Inflammatory Therapeutics Market Overview
10.1.2 North America Anti-Inflammatory Therapeutics Market Forecasts and Analysis
10.1.3 North America Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Drug Type
10.1.4 North America Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Indication
10.1.5 North America Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Anti-Inflammatory Therapeutics Market
10.1.6.1.1 United States Anti-Inflammatory Therapeutics Market by Drug Type
10.1.6.1.2 United States Anti-Inflammatory Therapeutics Market by Indication
10.1.6.1.3 United States Anti-Inflammatory Therapeutics Market by Distribution Channel
10.1.6.2 Canada Anti-Inflammatory Therapeutics Market
10.1.6.2.1 Canada Anti-Inflammatory Therapeutics Market by Drug Type
10.1.6.2.2 Canada Anti-Inflammatory Therapeutics Market by Indication
10.1.6.2.3 Canada Anti-Inflammatory Therapeutics Market by Distribution Channel
10.1.6.3 Mexico Anti-Inflammatory Therapeutics Market
10.1.6.3.1 Mexico Anti-Inflammatory Therapeutics Market by Drug Type
10.1.6.3.2 Mexico Anti-Inflammatory Therapeutics Market by Indication
10.1.6.3.3 Mexico Anti-Inflammatory Therapeutics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Anti-Inflammatory Therapeutics Market Overview
10.2.2 Europe Anti-Inflammatory Therapeutics Market Forecasts and Analysis
10.2.3 Europe Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Indication
10.2.5 Europe Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Anti-Inflammatory Therapeutics Market
10.2.6.1.1 Germany Anti-Inflammatory Therapeutics Market by Drug Type
10.2.6.1.2 Germany Anti-Inflammatory Therapeutics Market by Indication
10.2.6.1.3 Germany Anti-Inflammatory Therapeutics Market by Distribution Channel
10.2.6.2 France Anti-Inflammatory Therapeutics Market
10.2.6.2.1 France Anti-Inflammatory Therapeutics Market by Drug Type
10.2.6.2.2 France Anti-Inflammatory Therapeutics Market by Indication
10.2.6.2.3 France Anti-Inflammatory Therapeutics Market by Distribution Channel
10.2.6.3 Italy Anti-Inflammatory Therapeutics Market
10.2.6.3.1 Italy Anti-Inflammatory Therapeutics Market by Drug Type
10.2.6.3.2 Italy Anti-Inflammatory Therapeutics Market by Indication
10.2.6.3.3 Italy Anti-Inflammatory Therapeutics Market by Distribution Channel
10.2.6.4 Spain Anti-Inflammatory Therapeutics Market
10.2.6.4.1 Spain Anti-Inflammatory Therapeutics Market by Drug Type
10.2.6.4.2 Spain Anti-Inflammatory Therapeutics Market by Indication
10.2.6.4.3 Spain Anti-Inflammatory Therapeutics Market by Distribution Channel
10.2.6.5 United Kingdom Anti-Inflammatory Therapeutics Market
10.2.6.5.1 United Kingdom Anti-Inflammatory Therapeutics Market by Drug Type
10.2.6.5.2 United Kingdom Anti-Inflammatory Therapeutics Market by Indication
10.2.6.5.3 United Kingdom Anti-Inflammatory Therapeutics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Anti-Inflammatory Therapeutics Market Overview
10.3.2 Asia-Pacific Anti-Inflammatory Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Anti-Inflammatory Therapeutics Market
10.3.6.1.1 Australia Anti-Inflammatory Therapeutics Market by Drug Type
10.3.6.1.2 Australia Anti-Inflammatory Therapeutics Market by Indication
10.3.6.1.3 Australia Anti-Inflammatory Therapeutics Market by Distribution Channel
10.3.6.2 China Anti-Inflammatory Therapeutics Market
10.3.6.2.1 China Anti-Inflammatory Therapeutics Market by Drug Type
10.3.6.2.2 China Anti-Inflammatory Therapeutics Market by Indication
10.3.6.2.3 China Anti-Inflammatory Therapeutics Market by Distribution Channel
10.3.6.3 India Anti-Inflammatory Therapeutics Market
10.3.6.3.1 India Anti-Inflammatory Therapeutics Market by Drug Type
10.3.6.3.2 India Anti-Inflammatory Therapeutics Market by Indication
10.3.6.3.3 India Anti-Inflammatory Therapeutics Market by Distribution Channel
10.3.6.4 Japan Anti-Inflammatory Therapeutics Market
10.3.6.4.1 Japan Anti-Inflammatory Therapeutics Market by Drug Type
10.3.6.4.2 Japan Anti-Inflammatory Therapeutics Market by Indication
10.3.6.4.3 Japan Anti-Inflammatory Therapeutics Market by Distribution Channel
10.3.6.5 South Korea Anti-Inflammatory Therapeutics Market
10.3.6.5.1 South Korea Anti-Inflammatory Therapeutics Market by Drug Type
10.3.6.5.2 South Korea Anti-Inflammatory Therapeutics Market by Indication
10.3.6.5.3 South Korea Anti-Inflammatory Therapeutics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Anti-Inflammatory Therapeutics Market Overview
10.4.2 Middle East and Africa Anti-Inflammatory Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Anti-Inflammatory Therapeutics Market
10.4.6.1.1 South Africa Anti-Inflammatory Therapeutics Market by Drug Type
10.4.6.1.2 South Africa Anti-Inflammatory Therapeutics Market by Indication
10.4.6.1.3 South Africa Anti-Inflammatory Therapeutics Market by Distribution Channel
10.4.6.2 Saudi Arabia Anti-Inflammatory Therapeutics Market
10.4.6.2.1 Saudi Arabia Anti-Inflammatory Therapeutics Market by Drug Type
10.4.6.2.2 Saudi Arabia Anti-Inflammatory Therapeutics Market by Indication
10.4.6.2.3 Saudi Arabia Anti-Inflammatory Therapeutics Market by Distribution Channel
10.4.6.3 U.A.E Anti-Inflammatory Therapeutics Market
10.4.6.3.1 U.A.E Anti-Inflammatory Therapeutics Market by Drug Type
10.4.6.3.2 U.A.E Anti-Inflammatory Therapeutics Market by Indication
10.4.6.3.3 U.A.E Anti-Inflammatory Therapeutics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Anti-Inflammatory Therapeutics Market Overview
10.5.2 South and Central America Anti-Inflammatory Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Anti-Inflammatory Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Anti-Inflammatory Therapeutics Market
10.5.6.1.1 Brazil Anti-Inflammatory Therapeutics Market by Drug Type
10.5.6.1.2 Brazil Anti-Inflammatory Therapeutics Market by Indication
10.5.6.1.3 Brazil Anti-Inflammatory Therapeutics Market by Distribution Channel
10.5.6.2 Argentina Anti-Inflammatory Therapeutics Market
10.5.6.2.1 Argentina Anti-Inflammatory Therapeutics Market by Drug Type
10.5.6.2.2 Argentina Anti-Inflammatory Therapeutics Market by Indication
10.5.6.2.3 Argentina Anti-Inflammatory Therapeutics Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTI-INFLAMMATORY THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. ABBVIE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MERCK AND CO., INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. NOVARTIS AG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCHE AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ELI LILY AND COMPANY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ASTRAZENECA PLC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. AMGEN INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. JOHNSON AND JOHNSON SERVICES INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AbbVie Inc.
2. Pfizer Inc.
3. GlaxoSmithKline plc
4. Merck and Co., Inc.
5. Novartis AG
6. F. Hoffmann-La Roche AG
7. Eli Lily and Company
8. AstraZeneca PLC.
9. Amgen Inc.
10. Johnson and Johnson Services Inc.